Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Michael Grossman

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Circulation. Cardiovascular Interventions|November 11, 2010
Defining the optimal degree of heparin anticoagulation for peripheral vascular interventions: insight from a large, regional, multicenter registryChristos Kasapis, Hitinder S Gurm, Stanley J Chetcuti, et al.
Neuroepidemiology|October 11, 2007
Screening for myocardial infarction and ischemic stroke: a population-based studyDevin L Brown, Lynda D Lisabeth, Stanley J Chetcuti, et al.
The Annals of Thoracic Surgery|August 10, 2019
Early Structural Valve Degeneration of Trifecta BioprosthesisShinichi Fukuhara, Suzuna Shiomi, Bo Yang, et al.
The Journal of Cardiovascular Management : the Official Journal of the American College of Cardiovascular Administrators|September 21, 2005
Shelf-price agreements: the next frontier in competitive bidding for coronary intervention suppliesRobert K Keast, Kim A Eagle, Julie Goldstein-Dunn, et al.
Vascular Medicine (London, England)|November 21, 2015
Phase I study of multi-gene cell therapy in patients with peripheral artery diseaseP Michael Grossman, Emile R Mohler, Blake J Roessler, et al.
Circulation. Cardiovascular Interventions|March 15, 2021
Surgical Explantation of Transcatheter Aortic Valve Bioprostheses: A Statewide ExperienceAlexander A Brescia, G Michael Deeb, Stephane Leung Wai Sang, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Transcatheter Aortic Valve Replacement for Left Ventricular Assist Device-Related Aortic Regurgitation: The Michigan Medicine ExperienceKeerthi T Gondi, Marty C Tam, Stanley J Chetcuti, et al.
The American Journal of Cardiology|October 15, 2003
Impact of extracardiac vascular disease on acute prognosis in patients who undergo percutaneous coronary interventions (data from the Blue Cross & Blue Shield of Michigan Cardiovascular Consortium [BMC2])Debabrata Mukherjee, Kim A Eagle, Dean E Smith, et al.
The Journal of Invasive Cardiology|January 1, 2018
Association of Anemia With Outcomes in Patients Undergoing Percutaneous Peripheral Vascular Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2 VIC)Nikhil V Ambulgekar, Scott F Grey, Howard S Rosman, et al.
JACC. Cardiovascular Imaging|November 19, 2018
Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic StenosisStanley J Chetcuti, G Michael Deeb, Jeffrey J Popma, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Circulation. Cardiovascular Interventions|November 11, 2010
Defining the optimal degree of heparin anticoagulation for peripheral vascular interventions: insight from a large, regional, multicenter registryChristos Kasapis, Hitinder S Gurm, Stanley J Chetcuti, et al.
Neuroepidemiology|October 11, 2007
Screening for myocardial infarction and ischemic stroke: a population-based studyDevin L Brown, Lynda D Lisabeth, Stanley J Chetcuti, et al.
The Annals of Thoracic Surgery|August 10, 2019
Early Structural Valve Degeneration of Trifecta BioprosthesisShinichi Fukuhara, Suzuna Shiomi, Bo Yang, et al.
The Journal of Cardiovascular Management : the Official Journal of the American College of Cardiovascular Administrators|September 21, 2005
Shelf-price agreements: the next frontier in competitive bidding for coronary intervention suppliesRobert K Keast, Kim A Eagle, Julie Goldstein-Dunn, et al.
Vascular Medicine (London, England)|November 21, 2015
Phase I study of multi-gene cell therapy in patients with peripheral artery diseaseP Michael Grossman, Emile R Mohler, Blake J Roessler, et al.
Circulation. Cardiovascular Interventions|March 15, 2021
Surgical Explantation of Transcatheter Aortic Valve Bioprostheses: A Statewide ExperienceAlexander A Brescia, G Michael Deeb, Stephane Leung Wai Sang, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Transcatheter Aortic Valve Replacement for Left Ventricular Assist Device-Related Aortic Regurgitation: The Michigan Medicine ExperienceKeerthi T Gondi, Marty C Tam, Stanley J Chetcuti, et al.
The American Journal of Cardiology|October 15, 2003
Impact of extracardiac vascular disease on acute prognosis in patients who undergo percutaneous coronary interventions (data from the Blue Cross & Blue Shield of Michigan Cardiovascular Consortium [BMC2])Debabrata Mukherjee, Kim A Eagle, Dean E Smith, et al.
The Journal of Invasive Cardiology|January 1, 2018
Association of Anemia With Outcomes in Patients Undergoing Percutaneous Peripheral Vascular Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2 VIC)Nikhil V Ambulgekar, Scott F Grey, Howard S Rosman, et al.
JACC. Cardiovascular Imaging|November 19, 2018
Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic StenosisStanley J Chetcuti, G Michael Deeb, Jeffrey J Popma, et al.
Pageof 6